{"organizations": [], "uuid": "29ff5a4f7885e56c42f318d26b94434215da6376", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-provides-full-approval-to-prax/brief-fda-provides-full-approval-to-praxbind-specific-reversal-agent-for-pradaxa-idUSASC09W3T", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Provides Full Approval To Praxbind, Specific Reversal Agent For Pradaxa", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-04-17T20:08:00.000+03:00", "replies_count": 0, "uuid": "29ff5a4f7885e56c42f318d26b94434215da6376"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-provides-full-approval-to-prax/brief-fda-provides-full-approval-to-praxbind-specific-reversal-agent-for-pradaxa-idUSASC09W3T", "ord_in_thread": 0, "title": "BRIEF-FDA Provides Full Approval To Praxbind, Specific Reversal Agent For Pradaxa", "locations": [], "entities": {"persons": [], "locations": [{"name": "praxbind", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "axa", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17 (Reuters) - FDA-\n* FDA PROVIDES FULL APPROVAL TO PRAXBIND, SPECIFIC REVERSAL AGENT FOR PRADAXA\n* BOEHRINGER INGELHEIM SAYS U.S. FDA PROVIDED FULL APPROVAL FOR PRAXBIND , THE SPECIFIC REVERSAL AGENT FOR PRADAXA Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-17T20:08:00.000+03:00", "crawled": "2018-04-18T18:13:57.000+03:00", "highlightTitle": ""}